FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Clintabs Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Keep out of reach of children. Not for human use.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Clintabs (brand of clindamycin hydrochloride) Tablets (for use in dogs only) are indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below:
Skin infections (wounds and abscesses) due to: coagulase positive staphylococci (Staphylococcus aureus or Staphylococcus intermedius).
Deep wounds and abscesses due to Bateroides fragilis, Prevotella melaninogenicus, Fusobacterium necrophorum and Clostridium perfringens.
Dental infections due to Staphyloccus aureus, Bacteroides fragilis, Prevotella melaninogenicus, Fusobacterium necrophorum and Clostridium perfringens.
Osteomyelitis due to Staphylococcus aureus, Bacteroides fragilis, Prevotella melaninogenicus, Fusobacterium necrophorum and Clostridium perfringens.
History
There is currently no drug history available for this drug.
Other Information
Clintabs Tablets contain clindamycin hydrochloride which is the hydrated salt of clindamycin. Clindamycin is a semisyntheic antibiotic produced by a 7(S)-chlorosubstitution of the 7(R)-hydroxyl group of a naturally produced antibiotic produced by Streptomyces lincolnensis var. lincolnensis.
25 mg Tablet, each white bisected tablet is marked "C" above the bisect and "25" below the bisect and contains clindamycin hydrochloride equivalent to 25 mg of clindamycin.
75 mg Tablet, each white bisected tablet is marked "C" above the bisect and "75" below the bisect and contains clindamycin hydrochloride equivalent to 75 mg of clindamycin.
150 mg Tablet, each white tablet is marked "C 150" on one side and contains clindamycin hydrochloride equivalent to 150 mg of clindamycin.
Sources
Clintabs Manufacturers
-
Virbac Ah, Inc.
Clintabs | Virbac Ah, Inc.
Dogs Infected Wounds, Abscesses, and Dental Infections Oral2.5-15.0 mg/lb body weight every 12 hours.
DurationTreatment with clindamycin hydrochloride products may be continued up to a maximum of 28 days if clinical judgment indicates. Treatment of acute infections should not be continued for more than three or four days if no response to therapy is seen.
Dosage Schedule TabletsClintabs 25 mg, administer 1-6 tablets every 12 hours for each 10 pounds of body weight.
Clintabs 75 mg, administer 1-6 tablets every 12 hours for each 30 pounds of body weight.
Clintabs 150 mg, administer 1-6 tablets every 12 hours for each 60 pounds of body weight.
Dogs Osteomyelitis Oral5.0-15.0 mg/lb body weight every 12 hours.
DurationTreatment with clindamycin hydrochloride is recommended for a minimum of 28 days. Treatment should not be continued for longer than 28 days if no response to therapy is seen.
Dosage Schedule TabletsClintabs 25 mg, administer 2-6 tablets every 12 hours for each 10 pounds of body weight.
Clintabs 75 mg, administer 2-6 tablets every 12 hour for each 30 pounds of body weight.
Clintabs 150 mg, administer 2-6 tablets every 12 hours for each 60 pounds of body weight.
Login To Your Free Account